Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-28 23:30:54 - browse：596

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： CDC concerned about possible undetected monkeypox spread in U.K.

entertainment

WSS

The story of mRNA: From a loose idea to a tool that may help curb Covid

Colonoscopy at 40? Study finds a possible benefit

Donald Trump's relentless attacks on special counsel Jack Smith

Snackable artificial intelligence, expert AI, and the pharma industry

Donald Trump's relentless attacks on special counsel Jack Smith

How generative AI is inspiring dreams of a health data revolution

hotspot

Wikipedia

focus

Jerome Adams on the need for new antivirals for Covid

NIH nominee Bertagnolli will get October confirmation hearing

Peter Hotez and the public health issue of online harassment

Paxlovid study fails to answer questions over benefit for broader groups

Hepatitis C has a cure — but many Americans still lack access to it

WATCH: Why do fingernails fall off when they're damaged?

Medicare proposal to cover medical devices draws a mixed reaction

Donald Trump's relentless attacks on special counsel Jack Smith

Heart attack and stroke risk calculators need revising

The science behind Janet Jackson's pregnancy at 49

leisure time

Trump surgeon general acknowledges mistakes during Covid

With FDA staff opposed to Sarepta therapy, top official intervened

#NeedHerScience: shining a light on gender disparities in medicine

Donald Trump's relentless attacks on special counsel Jack Smith

Ethical issues complicate the benefits of medical crowdfunding

Paxlovid study fails to answer questions over benefit for broader groups

Wikipedia

entertainment

leisure time

hotspot